Skip to main content
Glama

jean — Molecular Biology & Genomics

fold_guide

Read-only

Fold a guide RNA — the spacer alone, and the whole sgRNA on a real published scaffold — and report which bases of the spacer pair with the scaffold. A spacer that base-pairs into the scaffold disrupts the structure Cas9 binds, which is a physical cause of a dead guide rather than a score. Every free energy is a minimum-free-energy fold under the Turner 2004 nearest-neighbour parameters, in kcal/mol, cross-checked against ViennaRNA 2.7.2.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
_filesNoThe project: record references shaped like _subject. Their records become library documents a tool names in sequences/parts/document; a trace or alignment is found by file name.
sg_rnaNoalso fold the full spacer+scaffold sgRNA, not just the spacer.
spacerYesthe protospacer to fold.
_subjectNoThe record to act on: exactly one of sequence, accession (+source), sample (an id from list_samples) or file ({name, text} or {name, base64}); record_index picks one record of several.
nucleaseNopicks the scaffold published for that nuclease. Values: SpCas9 (SpCas9: NGG (3')), SpCas9-NG (SpCas9-NG: NG (3')), SpG (SpG: NGN (3')), SpRY (SpRY: NRN (3')), xCas9 (xCas9: NG (3')), SaCas9 (SaCas9: NNGRRT (3')), SaCas9-KKH (SaCas9-KKH: NNNRRT (3')), AsCas12a (AsCas12a: TTTV (5')), LbCas12a (LbCas12a: TTTV (5')), enAsCas12a (enAsCas12a: TTTV (5')).SpCas9

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault
sgRnaYesthe full sgRNA fold, when a scaffold is published for this nuclease
spacerYesthe spacer's own fold: sequence, dot-bracket structure and free energy
scaffoldNameYeswhich published scaffold was used. Null when no scaffold is published for this nuclease
scaffoldIntactYeswhether the scaffold still folds as published once the spacer is attached. Null when no scaffold is published for this nuclease: false would read as a disrupted scaffold
spacerScaffoldPairsYeshow many spacer bases pair INTO the scaffold — every one of them disrupts the structure Cas9 binds. Null when no scaffold is published for this nuclease

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A4/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, destructiveHint=false, and openWorldHint=false, so the safety profile is covered. The description adds real value beyond that: the energy model (Turner 2004 nearest-neighbour parameters, kcal/mol) and cross-validation against ViennaRNA 2.7.2, plus the fact that it reports pairing rather than a score. It stops short of discussing performance or limits, hence a 4.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three sentences, front-loaded with the core action, then rationale, then methodology. Every sentence carries information and none is filler, though the third sentence's tool-version detail is slightly dense.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With an output schema present, return values need not be re-explained, and annotations cover safety. The description still supplies the scientific framing, the output content (paired bases), the energy model, and scaffold-selection context, leaving nothing essential for a correct invocation missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents spacer, sg_rna, nuclease, and the _subject/_files references. The description adds only loose context (folding 'the spacer alone, and the whole sgRNA') that maps to the sg_rna flag, so the baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb (fold) and resource (a guide RNA / sgRNA on a published scaffold) and clarifies the deliverable: which spacer bases pair with the scaffold. The scope is narrow enough that an agent can tell it apart from the general-purpose fold_rna sibling without opening the schema.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The rationale (a spacer base-pairing into the scaffold physically disrupts Cas9 binding, causing a dead guide) implies when the tool is useful, but the description never explicitly states when to use it versus alternatives like fold_rna or the crispr scoring tools, nor any exclusions. Usage is implied rather than stated.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources